A Study of Magnesium and Bladder Spasms Following Ambulatory Urologic Procedures

NCT05806996 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-05-13

No results posted yet for this study

Summary

This research is being done to find out whether intravenous magnesium is effective in the treatment of bladder spasms after urologic surgery.

Conditions

  • Bladder Spasms

Interventions

DRUG

Magnesium

Intravenous infusion, load 50 mg/Kg with infusion of 15 mg/Kg/hour

DRUG

Placebo

Equivalent volume of normal saline

Sponsors & Collaborators

Principal Investigators

  • Gregory Nuttall, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-31
Primary Completion
2026-06-30
Completion
2026-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05806996 on ClinicalTrials.gov